Funding for this research was provided by:
Text and Data Mining valid from 2019-05-22
Received: 20 December 2018
Accepted: 23 April 2019
First Online: 22 May 2019
Ethics approval and consent to participate
: All patients provided written informed consent. The study was performed in accordance with a protocol approved by the IRB at Rutgers, The State University of New Jersey, in accordance with the ethical principles originating in the Declaration of Helsinki, and was consistent with International Conference on Harmonization/Good Clinical Practice guidelines and applicable regulatory requirements.
: Not applicable.
: Rohinton S. Tarapore, Varun V. Prabhu, Joshua E. Allen, Martin Stogniew, and Wolfgang Oster are employees and shareholders of Oncoceutics. Joseph Bertino is a shareholder of Oncoceutics. Wafik S. El-Deiry is the Scientific Founder of Oncoceutics and a shareholder and is compliant with institutional and NIH guidelines for disclosure of conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.